Professor Vijay Sangar studied Medicine at the The University of Manchester where he obtained a 1st Class Honours degree in Anatomy followed by his primary medical degree (MB.ChB.). Subsequently he spent some time at the Cancer Research UK Laboratories (Paterson Institute for Cancer Research/Christie Hospital) in Manchester studying treatments for bladder cancer, which led to the award of a Doctorate of Medicine (MD). Vijay trained in General Urology in the North West of England, undertaking specialist training in Urological Cancer management at the Christie Hospital during which he obtained his Certificate of Specialist Training and his Specialist Urological Fellowship of The Royal College of Surgeons. He then became a Consultant Urological Surgeon/Urologist at The Christie Hospital and University Hospital of South Manchester (now Manchester University Hospital NHS Foundation Trust). Vijay was appointed Professor of Surgery at the Manchester Academic Health Sciences Centre (MAHSC) in 2018.
Vijay has developed expertise as a Urological Surgeon specialising in conditions that effect Men. He is one of the leading penile specialists in the UK and Europe. Vijays expertise includes problems with the Penis, Testis, Scrotum and Prostate/Bladder, encompassing lumps, bumps, erectile dysfunction, peyronies, infertility, vasectomy, vasectomy reversal, circumcision (including redo procedures), problems passing urine and cancer detection. He also undertakes Penile reconstructive work (but not full phalloplasty) for cancer patients and those suffering from Peyronies disease. He is a key leader in new treatments for erectile dysfunction, such as ED1000. He has a range of therapies for peyronies disease and is currently one of only a handful of Accredited National Trainers for Xiapex therapy, which is used for the treatment of Peyronies disease.
Alongside this expertise he is established as a member of the Pelvic Mutlidiscplinary Team at the Christie. This Team works to help treat patients with complex and or rare cancers, and those who may have had therapy but are sufferring from side effects which require attention. Mr Sangar has expertise in survivorship issues related to cancer including erectile dysfunction and urinary problems.
Alongside his surgical practice Vijay is a member of NHS Englands Clinical Panel and Lead for Rare Urogenital Cancers in the eUROGEN European Reference Network. He has previously held prestigious appointments including: Director of Surgery at The Christie Hospital, Chair of the North West Penile Service, Chair of NHS Englands Specialised Cancer Surgery Clinical Reference Group and Chair of NHS Englands Cancer Surgery Metrics Group. These require him to work closely with mutliple National and European Organsiations including the Royal Colleges, CQC, NICE, NCRI, European Assoc of Urology, European Commission and BAUS. He has an active research porfolio, publishing in many international journals and is the holder of prestigous international prizes.
GMC Number: 4013107
Current NHS Posts
Consultant Urological Surgeon
The Christie Hospital NHS Foundation Trust
Consultant Urological Surgeon
Manchester University Hospital NHS Foundation Trust
Professor of Surgery, Manchester Academic Health Sciences Centre (MAHSC), Manchester UK
Other Posts: Member of Clinical Panel, NHS England, Member NCRI Penile Cancer Studies Sub-Group, Lead for eUROGEN European Ref Network WS3, Member of Advisory Panel to CQC, Member of Advisory Panel National Prostate Cancer Audit, Past Member RCS Penile Cancer Sentinel Node Steering Committee, Past Executive Committee Member BAUS Sections of Oncology and Andrology
Associations: British Association of Urological Surgeons, European Association of Urology, BAUS Section of Oncology & Section of Andrology
The world of medicine is in a state of constant flux. This is where we will provide you with a selection of interesting news about the medical world and our practice.
Prostate SelectMDx is now available at our clinics. Please call in advance if you wish to be considered for this test.
New therapies (Fortacin) for Premature Ejaculation now available at Urology Clinics (April 2019)
Shock wave therapy can assist in Peyronies disease & Prostatitis (April 2019).
Peyronies disease can now be treated with collagenase injections (XIAPEX) (Jan 2018).
Multi-parametric MR scanning of the prostate can help in diagnosing prostate cancer. Available at Spire Manchester and The Chrsitie Clinic.